165 related articles for article (PubMed ID: 21560455)
1. [Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes].
Tvarůzková Z; Pavlová S; Doubek M; Mayer J; Pospísilová S
Cas Lek Cesk; 2011; 150(3):161-8. PubMed ID: 21560455
[TBL] [Abstract][Full Text] [Related]
2. Infections and autoimmune diseases.
Bach JF
J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
[TBL] [Abstract][Full Text] [Related]
3. The dual association between lymphoma and autoimmunity.
Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
[TBL] [Abstract][Full Text] [Related]
4. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
6. Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma.
Krueger GR; Manak M; Bourgeois N; Ablashi DV; Salahuddin SZ; Josephs SS; Buchbinder A; Gallo RC; Berthold F; Tesch H
Anticancer Res; 1989; 9(6):1457-76. PubMed ID: 2560617
[TBL] [Abstract][Full Text] [Related]
7. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
8. Extrahepatic manifestations in patients with chronic hepatitis C virus infection.
Ramos-Casals M; Font J
Curr Opin Rheumatol; 2005 Jul; 17(4):447-55. PubMed ID: 15956842
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
Sokol H; Beaugerie L
Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative diseases of uncertain classification.
Monteverde A; Pileri S
Ann Ital Med Int; 1991; 6(1 Pt 2):162-70. PubMed ID: 1742152
[TBL] [Abstract][Full Text] [Related]
11. Immunodeficiency-associated lymphoproliferative disorders.
Knowles DM
Mod Pathol; 1999 Feb; 12(2):200-17. PubMed ID: 10071343
[TBL] [Abstract][Full Text] [Related]
12. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
Smedby KE; Baecklund E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2069-77. PubMed ID: 17119030
[TBL] [Abstract][Full Text] [Related]
13. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders.
Polliack A; Lugassy G
Leukemia; 1992 Nov; 6 Suppl 4():152-4. PubMed ID: 1434818
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
17. Malignancies in autoimmune rheumatic diseases - a mini-review.
Szekanecz Z; Szekanecz E; Bakó G; Shoenfeld Y
Gerontology; 2011; 57(1):3-10. PubMed ID: 20453490
[TBL] [Abstract][Full Text] [Related]
18. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
19. Retroviruses in autoimmune liver disease: genetic or environmental agents?
Mason AL; Xu L; Guo L; Garry RF
Arch Immunol Ther Exp (Warsz); 1999; 47(5):289-97. PubMed ID: 10604234
[TBL] [Abstract][Full Text] [Related]
20. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
Kojima M; Motoori T; Nakamura S
Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
